4/A//SEC Filing
Mattsson Jan 4/A
Accession 0001209191-21-018051
CIK 0001322505other
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 6:08 AM ET
Size
18.2 KB
Accession
0001209191-21-018051
Insider Transaction Report
Form 4/AAmended
Mattsson Jan
Chief Operating Officer
Transactions
- Exercise/Conversion
Common Stock
2021-03-01$1.00/sh+39,330$39,330→ 69,044 total - Sale
Common Stock
2021-03-01$37.45/sh−15,300$572,996→ 53,744 total - Sale
Common Stock
2021-03-02$36.07/sh−12,351$445,561→ 41,393 total - Sale
Common Stock
2021-03-02$36.54/sh−612$22,365→ 40,781 total - Sale
Common Stock
2021-03-02$37.15/sh−2,807$104,281→ 37,974 total - Sale
Common Stock
2021-03-03$36.20/sh−400$14,481→ 37,574 total - Exercise/Conversion
Stock Option (right to buy)
2021-03-01−39,330→ 0 totalExercise: $1.00Exp: 2021-03-18→ Common Stock (39,330 underlying)
Footnotes (12)
- [F1]Represents 63,544 shares of common stock and 5,500 restricted stock units.
- [F10]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.00 to $36.27, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price within the range set forth above.
- [F11]Represents 32,074 shares of common stock and 5,500 restricted stock units.
- [F12]This option is fully vested.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.10 to $37.81, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price within the range set forth above.
- [F3]Represents 48,244 shares of common stock and 5,500 restricted stock units.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.00 to $36.46, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price within the range set forth above.
- [F5]Represents 35,893 shares of common stock and 5,500 restricted stock units.
- [F6]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.52 to $36.62, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price within the range set forth above.
- [F7]Represents 35,281 shares of common stock and 5,500 restricted stock units.
- [F8]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.00 to $37.20, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price within the range set forth above.
- [F9]Represents 32,474 shares of common stock and 5,500 restricted stock units.
Documents
Issuer
ALBIREO PHARMA, INC.
CIK 0001322505
Entity typeother
Related Parties
1- filerCIK 0001687436
Filing Metadata
- Form type
- 4/A
- Filed
- Mar 4, 7:00 PM ET
- Accepted
- Mar 5, 6:08 AM ET
- Size
- 18.2 KB